Gould Terry P Insider Trades

Insider Trading History

Track insider trading activity for Gould Terry P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $176k 15,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 15,000 shares
$2.12
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $176k 15,000 shares
Last Trade
Dec 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.6k 15,000 shares
$1.64
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $176k 15,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.4k 15,000 shares
$2.49
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
Director
Holding Value $176k 15,000 shares
Last Trade
Aug 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.5k 15,000 shares
$0.96
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
Director
Holding Value $176k 15,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.8k 15,000 shares
$0.99
$11.72
Aptinyx
Aptinyx APTX
Director
Holding Value $3.84k 40,000 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20k 40,000 shares
$0.50
$0.10
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $176k 15,000 shares
Last Trade
Sep 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39k 15,000 shares
$2.60
$11.72
Icosavax
Icosavax ICVX
Director
Holding Value $0 0 shares
Last Trade
Aug 02, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$26.3M 1,015,719 shares
$25.94
$15.31
Icosavax
Icosavax ICVX
Director
Holding Value $14.5M 948,188 shares
Last Trade
Aug 02, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$84.5M 3,259,058 shares
$25.94
$15.31
Icosavax
Icosavax ICVX
Director
Holding Value $15.3M 996,169 shares
Last Trade
Aug 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.46M 133,334 shares
$25.94
$15.31
Icosavax
Icosavax ICVX
10% owner
Holding Value $0 0 shares
Last Trade
Jul 28, 2021 Sale
No data
No data
$15.31
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $176k 15,000 shares
Last Trade
Jun 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.1k 15,000 shares
$2.74
$11.72
Aptinyx
Aptinyx APTX
Director
Holding Value $3.84k 40,000 shares
Last Trade
May 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$104k 40,000 shares
$2.59
$0.10
Aptinyx
Aptinyx APTX
Director
Holding Value $432 4,496 shares
Last Trade
Dec 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.6k 4,496 shares
$3.46
$0.10
Aptinyx
Aptinyx APTX
10% owner
Holding Value $444 4,623 shares
Last Trade
Sep 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.6k 4,623 shares
$3.38
$0.10
Aptinyx
Aptinyx APTX
10% owner
Holding Value $359 3,735 shares
Last Trade
Jun 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.6k 3,735 shares
$4.17
$0.10
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $176k 15,000 shares
Last Trade
Jun 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49.1k 15,000 shares
$3.27
$11.72
Aptinyx
Aptinyx APTX
10% owner
Holding Value $3.84k 40,000 shares
Last Trade
May 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$154k 40,000 shares
$3.84
$0.10
Aptinyx
Aptinyx APTX
10% owner
Holding Value $708 7,374 shares
Last Trade
Mar 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.9k 7,374 shares
$2.16
$0.10
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $176k 15,000 shares
Last Trade
Mar 19, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30k 15,000 shares
$2.00
$11.72

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up